Q1 2025 13F Holders as of 31 Mar 2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
106,018,136
-
Total 13F shares
-
72,275,286
-
Share change
-
+2,933,319
-
Total reported value
-
$197,291,658
-
Price per share
-
$2.73
-
Number of holders
-
113
-
Value change
-
+$5,448,211
-
Number of buys
-
50
-
Number of sells
-
57
Institutional Holders of MAXCYTE, INC. - Common Stock (MXCT) as of Q1 2025
As of 31 Mar 2025,
MAXCYTE, INC. - Common Stock (MXCT) was held by
113 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
72,275,286 shares.
The largest 10 holders included
CADIAN CAPITAL MANAGEMENT, LP, BlackRock, Inc., MORGAN STANLEY, VANGUARD GROUP INC, Vitruvian Partners LLP, MIRABELLA FINANCIAL SERVICES LLP, Mudita Advisors LLP, FMR LLC, GEODE CAPITAL MANAGEMENT, LLC, and Chevy Chase Trust Holdings, LLC.
This page lists
113
institutional shareholders reporting positions in this security
for the Q1 2025 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.